NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SQUAREPOINT OPS LLC | 11/14/2025 | 95.38 K | $119.22 K | 91.04% | 0.38% |
| MORGAN STANLEY | 11/14/2025 | 66.40 K | $83.00 K | -16.90% | 0.26% |
| MEITAV INVESTMENT HOUSE LTD | 10/29/2025 | 40.00 K | $50.00 K | 0.00% | 0.16% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 21.09 K | $26.36 K | 100.00% | 0.08% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 21.08 K | $26.00 K | 0.00% | 0.08% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 15.87 K | $19.84 K | 0.00% | 0.06% |
| UBS GROUP AG | 11/13/2025 | 14.66 K | $18.32 K | 809.93% | 0.06% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 1.46 K | $1.82 K | -67.34% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 11/04/2025 | 1.00 K | $1.24 K | -90.84% | 0.00% |
| CWM, LLC | 10/15/2025 | 1.00 K | $1.00 K | 0.00% | 0.00% |
| TOTAL INVESTMENT MANAGEMENT INC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| HURLEY CAPITAL, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| YORKVILLE ADVISORS GLOBAL, LP | 11/18/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
Squarepoint Ops LLC: 95,375
MORGAN STANLEY: 66,400
MEITAV INVESTMENT HOUSE LTD: 40,000
TWO SIGMA INVESTMENTS, LP: 21,086
COMMONWEALTH EQUITY SERVICES, LLC: 21,080
GEODE CAPITAL MANAGEMENT, LLC: 15,870
1.09% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 277.93 K shares in the last 24 months. This purchase volume represents approximately $347.41 K in transactions.